Wednesday, 14 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 6, 2026

Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise, oil tops $90

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise, oil tops $90 US stocks tumbled on Friday as the key monthly jobs report surprised to the downside and oil prices surged amid a deepening Middle East conflict, raising inflation worries…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Waiting for another 10% drop to Make Tech Value Again

    80% confidence

  • At this point, the Fed is facing two-sided risks

    80% confidence

  • If February's jobs report came in strong, he would switch to prefer holding rates steady, but given weak reading, he's likely to stick with bias to cut rates

    80% confidence

  • February's job report reflects structural changes in the job market where older Americans are retiring and companies are pausing hiring to see where AI can fill gaps

    80% confidence

  • The only path to resolution in Iran is 'UNCONDITIONAL SURRENDER'

    80% confidence

  • US will issue waiver allowing India to buy Russian oil stranded at sea

    80% confidence

  • With oil continuing to climb and shipping through Strait still disrupted, fuel prices are likely to keep rising through the weekend

    80% confidence

  • The Middle East conflict could 'bring down the economies of the world' and all Gulf energy exporters would shut down production within days, driving oil to $150 per barrel

    80% confidence

  • This jobs report has got my attention. The labor markets may be a little weaker than we have seen so far

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise, oil tops $90 — Source | Via News | ViaNews EU